A detailed history of Natixis transactions in Xoma Corp stock. As of the latest transaction made, Natixis holds 1,726 shares of XOMA stock, worth $51,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,726
Previous 1,726 -0.0%
Holding current value
$51,572
Previous $40,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$17.0 - $21.58 $7,463 - $9,473
-439 Reduced 20.28%
1,726 $32,000
Q1 2023

May 12, 2023

SELL
$18.01 - $23.12 $25,412 - $32,622
-1,411 Reduced 39.46%
2,165 $45,000
Q4 2022

Feb 24, 2023

BUY
$16.0 - $25.45 $57,216 - $91,009
3,576 New
3,576 $65,000

Others Institutions Holding XOMA

About XOMA Corp


  • Ticker XOMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,450,800
  • Market Cap $342M
  • Description
  • XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...
More about XOMA
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.